Advertisement
Advertisement
Advertisement
Advertisement
Weight loss medicine Ozempic reportedly takes woman’s life

Weight loss medicine Ozempic reportedly takes woman’s life

Weight loss medicine Ozempic reportedly takes woman’s life

Weight loss medicine Ozempic reportedly takes woman’s life

Advertisement
  • Weight loss medicine Ozempic reportedly takes a woman’s life.
  • Ozempic has gained attention on social media.
  • Trish Webster obtained a prescription but faced severe consequences.
Advertisement

A 56-year-old Australian woman, Trish Webster, tragically lost her life after reportedly taking the prescribed drug Ozempic to lose weight for her daughter’s wedding.

Ozempic, belonging to the GLP-1 class of drugs used to treat type 2 diabetes, has gained attention on social media, with influencers and celebrities allegedly using it for weight management.

The drug mimics the natural hormone GLP-1, signaling to the brain that the person is full. Trish Webster, inspired by a television ad, obtained a prescription but faced severe consequences, losing 16 kilograms in three months at the expense of her life.

Novo Nordisk, the manufacturer, stated that reports of complications emerged post-circulation, indicating a lack of prior awareness of the associated risks.

To stay informed about current events, please like our Facebook page https://www.facebook.com/BOLUrduNews/.

Follow us on Twitter https://twitter.com/bolnewsurdu01 and stay updated with the latest news.

Advertisement

Subscribe to our YouTube channel https://bit.ly/3Tv8a3P to watch news from Pakistan and around the world.

Also Read

Former Baltimore lawyer Marilyn Mosby convicted on 2 charges of perjury
Former Baltimore lawyer Marilyn Mosby convicted on 2 charges of perjury

Former Baltimore lawyer Marilyn Mosby was convicted on 2 charges of perjury....

Advertisement
Advertisement
Read More News On

Catch all the International News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Follow us on Google News.


End of Article

Next Story